2015
DOI: 10.1016/j.autrev.2014.10.011
|View full text |Cite
|
Sign up to set email alerts
|

GITR+ regulatory T cells in the treatment of autoimmune diseases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

2
59
0
1

Year Published

2016
2016
2022
2022

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 72 publications
(62 citation statements)
references
References 126 publications
2
59
0
1
Order By: Relevance
“…It has been known that phenotype of conventional T regs is CD4 + CD25 + FoxP3 + T cells [11, 28]. Moreover, GITR is also expressed on surface of typical CD4 + T regs [13]. In addition, 3G11 is a marker for specific subsets of CD4 + T regs [14, 15, 20, 29].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…It has been known that phenotype of conventional T regs is CD4 + CD25 + FoxP3 + T cells [11, 28]. Moreover, GITR is also expressed on surface of typical CD4 + T regs [13]. In addition, 3G11 is a marker for specific subsets of CD4 + T regs [14, 15, 20, 29].…”
Section: Discussionmentioning
confidence: 99%
“…Multiple T reg -associated molecules have been found since 1990s. For instance, glucocorticoid-induced tumor necrosis factor receptor (GITR) is also a molecular marker expressed on T regs [13]. 3G11, a sialylated carbohydrate epitope of the disialoganglioside molecule, is associated with definition of specific T reg subsets [14, 15]; however, regulatory mechanisms of T reg development and differentiation are still obscure.…”
Section: Introductionmentioning
confidence: 99%
“…However, a recent review article discussing data from mouse and human studies has suggested that GITR is a crucial player in the differentiation of thymic Tregs (tTregs), and expansion of both tTregs and peripheral Tregs (pTregs) [31]. Moreover, the authors have suggested two potential new approaches for treating autoimmune diseases consisting of the in vivo expansion of GITR + Tregs by GITR-triggering drugs and in vitro expansion of autologous or heterologous GITR + Tregs to be infused in the patients [32].…”
Section: Regulatory T Cells (Tregs) and Autoimmunitymentioning
confidence: 99%
“…The transcription factor FOXP3 binds to the enhancer region of Gitr and further activates Gitr gene transcription [4,5]. Notably, in the condition of autoimmune diseases, the dysfunction or instability of Treg cells is correlated with a decreased expression of GITR and a hyperactivation of Teff cells [6][7][8][9]. Meanwhile, GITR-deficient mice display a lower number of Treg cells [10].…”
mentioning
confidence: 99%